The Lodge analyst said 0.30 before and up to 0.50 afterwards.
At 0.10 a market cap of 83 millions is just nonsenses for a successful biotech with positive clinical Trial readout.
Ann: Factor Therapeutics Appoints Transaction Advisor, page-32
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
